Product
Lucerastat
1 clinical trial
1 indication
Indication
Fabry DiseaseClinical trial
A Multi-center, Open-label, Uncontrolled, Single-arm, Extension Study to Determine the Long-term Safety and Tolerability of Oral Lucerastat in Adult Subjects With Fabry DiseaseStatus: Active (not recruiting), Estimated PCD: 2025-10-29